Results 1 to 10 of about 206,766 (202)

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety [PDF]

Vaccine, 2014
The Vaccine Safety Datalink (VSD) is a collaborative project between the Centers for Disease Control and Prevention (CDC) and 9 health care organizations. Established in 1990, VSD is a vital resource informing policy makers and the public about the safety of vaccines used in the United States.
Michael M Mcneil, Julianne Gee, Eric S Weintraub   +2 more
exaly   +3 more sources

Examining Discordance in Perceptions of COVID-19 and Influenza Vaccine Safety During Pregnancy Among a Cohort of US Adults [PDF]

Vaccines
Background/Objectives: Vaccination is an important strategy to protect pregnant people, fetuses, and infants from severe influenza and COVID-19. However, as of April 2025 in the United States, only 14% of pregnant women had received the 2024–2025 COVID ...
Rachael Piltch-Loeb, Bai Xi Jasmine Chan, Josefina Nuñez Sahr, Chloe Teasdale, Sasha Fleary, Kate Penrose, Jenna Sanborn, Subha Balasubramanian, McKaylee Robertson, Angela Parcesepe   +9 more
doaj   +2 more sources

Strengthening Vaccine Safety Systems, Research, and Regional Collaboration in Africa: A Call to Action [PDF]

Vaccines
The 8th meeting of the African Advisory Committee on Vaccine Safety (AACVS), constituted in 2021, convened by the Vaccine Research and Innovation Unit within the Vaccine Preventable Diseases Program, WHO Regional Office for Africa, was held virtually ...
Beckie N. Tagbo, Chioma S. Ejekam, Winfred Oppong-Amoako, Tene Marceline Yameogo, Afework Mitiku, Dorothy O. Esangbedo, Nelisiwe Khuzwayo, Gugu Mahlangu, Samia M. Badar, Edinam A. Agbenu, Rhanda M. Adechina, Kwasi A. Nyarko   +11 more
doaj   +2 more sources

The use of observed-to-expected analyses as a signal detection tool in COVID-19 vaccine safety surveillance: lessons learned from an industry perspective [PDF]

Frontiers in Drug Safety and Regulation
During the pandemic, the accelerated review and authorization of coronavirus disease 19 (COVID-19) vaccines by regulatory authorities elicited the need for rapid and thorough worldwide signal detection and evaluation.
Laurence Serradell, Antonella Fretta, Jenny Nachbar, Jill Dreyfus, Diana Garofalo, Arianna Lucini, Susan Mather, Daina Esposito, Anne-Laure Chabanon, Vincent Bauchau, Sarah Sellers   +10 more
doaj   +2 more sources

A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee [PDF]

Osong Public Health and Research Perspectives, 2023
With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events.
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi   +10 more
doaj   +1 more source

Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir

Pharmaceuticals, 2023
In 2019, EMA licensed intravenous (IV) zanamivir for severe influenza virus infection in children over 6 months as well as adults. Prior to that, it was possible via a compassionate use program.
Maren Alchikh, Patrick E. Obermeier, Brunhilde Schweiger, Barbara A. Rath   +3 more
doaj   +1 more source

Incidence, Disease Severity, and Follow-Up of Influenza A/A, A/B, and B/B Virus Dual Infections in Children: A Hospital-Based Digital Surveillance Program

Viruses, 2022
Influenza virus (IV) coinfection, i.e., simultaneous infection with IV and other viruses, is a common occurrence in humans. However, little is known about the incidence and clinical impact of coinfection with two different IV subtypes or lineages (“dual ...
Patrick E. Obermeier, Lea D. Seeber, Maren Alchikh, Brunhilde Schweiger, Barbara A. Rath   +4 more
doaj   +1 more source

Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink

Vaccine, 2023
Safety data on simultaneous vaccination (SV) with primary series monovalent COVID-19 vaccines and other vaccines are limited. We describe SV with primary series COVID-19 vaccines and assess 23 pre-specified health outcomes following SV among persons aged ≥5 years in the Vaccine Safety Datalink (VSD).We utilized VSD's COVID-19 vaccine surveillance data ...
Tat'Yana A. Kenigsberg, Kayla E. Hanson, Nicola P. Klein, Ousseny Zerbo, Kristin Goddard, Stanley Xu, W. Katherine Yih, Stephanie A. Irving, Laura P. Hurley, Jason M. Glanz, Robyn Kaiser, Lisa A. Jackson, Eric S. Weintraub   +12 more
openaire   +2 more sources

Attitudes toward COVID-19 and Other Vaccines: Comparing Parents to Other Adults, September 2022

Vaccines, 2023
Few analyses of COVID-19 vaccine attitudes also cover routine vaccines or focus on parents. In this cross-sectional study, we surveyed US adults in September 2022, immediately following the authorization of updated bivalent COVID-19 boosters for adults ...
Matthew Z. Dudley, Holly B. Schuh, Michelle Goryn, Jana Shaw, Daniel A. Salmon   +4 more
doaj   +1 more source

Vaccines - safety in pregnancy

Best Practice & Research Clinical Obstetrics & Gynaecology, 2021
Vaccination during pregnancy is important for active immunity of the mother against serious infectious diseases, and also for passive immunity of the neonate to infectious diseases with high morbidity and mortality. As a rule, live vaccines are contraindicated during pregnancy as they may cause fetal viremia/bacteremia.
Arora, Mala, Lakshmi, Rama
openaire   +2 more sources